Drug interaction classified as: synergy
Source: DDInter
Antiarrhythmic · Treatment for Lambert-Eaton myasthenic syndrome
Amifampridine blocks nerve terminal potassium channels. This action prolongs the action potential duration at the nerve terminal, leading to increased calcium influx. The increased intracellular calcium then enhances transmitter (acetylcholine) release.
l BREAST FEEDING
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
8 additional unreviewed or low-confidence interactions hidden because their provenance or source detail is insufficient.
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: BNF·Updated: 2026-05-13